Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-405P encodes a **pseudogene** of the U6 small nuclear RNA (snRNA) family. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional: they have lost protein-coding or RNA activity due to disabling mutations such as frameshifts or premature stop codons. The canonical U6 snRNA is a critical component of the spliceosomal machinery in eukaryotes, directly involved in pre-mRNA splicing as part of the U6 ribonucleoprotein. However, RNU6-405P does not produce functional snRNA and is annotated as nonfunctional by major genome databases. Pseudogenes can sometimes participate in regulatory functions, but specific activity for RNU6-405P has not been described. No disease association, biomarker role, or drug interaction is reported for RNU6-405P. In summary, **RNU6-405P is not a druggable target** and represents a genetically annotated pseudogene related to the highly conserved and functionally critical U6 snRNA involved in splicing in eukaryotic cells, but lacks functional activity as either an RNA molecule or a therapeutic target.
Not applicable; there are no drugs that target RNU6-405P, nor any established mechanism of action as a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 405, pseudogene (RNU6-405P).